Putnam Investments LLC Fate Therapeutics Inc Transaction History

Putnam Investments LLC

  • $73 Billion
  • Q4 2023

A detailed history of Putnam Investments LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Putnam Investments LLC holds 244,684 shares of FATE stock, worth $592,135. This represents 0.0% of its overall portfolio holdings.

Number of Shares
244,684
Previous 133,250 83.63%
Holding current value
$592,135
Previous $282,000 224.47%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$1.65 - $3.94 $183,866 - $439,049
111,434 Added 83.63%
244,684 $915,000
Q3 2023

Nov 14, 2023
BUY
$2.02 - $5.04 $269,165 - $671,580
133,250 New
133,250 $282,000

Others Institutions Holding FATE

# of Institutions
175
Shares Held
115M
Call Options Held
53.7K
Put Options Held
9K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $235M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Putnam Investments LLC Portfolio

Follow Putnam Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email